Medical oncologist & researcher at Institut Català d'Oncologia-Badalona @ICO_oncologia @GTRecerca- Thoracic Oncology and Sarcomas
Barcelona
Joined February 2021
- Tweets243
- Following345
- Followers338
- Likes857
ENTREVISTA | Ricard Mesía, ICO Badalona bdncom.cat/notice/entrevista… #Badalona
Acte de clausura #LungYoungConnection2025 🫁🩺Gràcies a tots/es per la participació💫! Ens veiem a la propera edició!👋
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study - The Lancet thelancet.com/journals/lance…
1
165
📍 B-ARGO Translational Research in Lung Cancer 5th Edition 🩺🫁 10th June | 13:00 - 17:00 Sala Polivalent IGTP Mar + online 🗓️germanstrias.org/ca/agenda/1…
@ICO_oncologia
@GTRecerca
📍Celebració del 20è aniversari de la unitat funcional de #sarcomes d'@ICO_oncologia Hospitalet-@hbellvitge . Enhorabona!!🥳🏥🩺
9
287
📢VIII Curs Immunoteràpia B-ARGO🩺🔬
🗓️6-7 Novembre 2024
🏥 Sala Polivalent IGTP Mar
✍️Link inscripció (gratuïta): forms.office.com/e/kTDsirs4z…
Doxorubicin-Trabectedin follwed by Trabectedin Maintenance in #Leiomyosarcoma, shows improved OS and PFS, as compared with Doxorubicin alone 💊🩺#LMS04 pubmed.ncbi.nlm.nih.gov/3923…
5
236
📍 B-ARGO Translational Research in Lung Cancer 4th Edition
🗓️ 18 June | 13:15 - 17:00 Sala Polivalent IGTP Mar + online
👉 Registration germanstrias.org/ca/agenda/8…
@ICO_oncologia @GTRecerca
Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors | American Society of Clinical Oncology Educational Book 2024 @ASCO ascopubs.org/doi/pdf/10.1200…
2
114
New Treatment Options for Patients With Oncogene-Addicted Non–Small Cell Lung Cancer Focusing on EGFR-Mutant Tumors | American Society of Clinical Oncology Educational Book 2024 @ASCO ascopubs.org/doi/pdf/10.1200…
🧬Exciting findings from our recent publication: High levels of HLA-I were linked to favorable clinical outcomes with ICI in NSCLC. Long-term responders showed enriched HLA-I-expressing tumors. Congrats to
@ICO_oncologia @GTRecerca @CarrerasIJC Team👏
sciencedirect.com/science/ar…
👏Congratulations to Dr.@SChekhun & the entire team for this case report exemplifying our multidisciplinary task: “Is oligoprogression a potentially curable disease in EGFR mutant lung adenocarcinoma?” 🩺🫁 @ICO_oncologia @GTRecerca @hgermanstrias
👉doi.org/10.37349/etat.2023.0…
Nova sessió de #LungYoungConnection 🫁 organitzada per @alvarotaus a @hospitaldelmar 👏🔝Ens veiem a la pròxima edició 2024-2025 ‼️ @Ivana_Sullivan
@jove_m83 @LauraMezquitaMD @ANavarro_MD
🔬Our study about Lung Cancer patients with KRAS mutations: KRAS G12C vs. non-G12C, treated with immunotherapy, is out at @FrontOncology Congrats to @DrNotarioR and all the team! 💫frontiersin.org/articles/10.…
@ICO_oncologia @GTRecerca @hgermanstrias
📢New edition: VII Curs Immunoteràpia B·ARGO
📍 Sala de Graus, edifici UAB-Can Ruti
🗓️ 4 i 5 Octubre 2023: 15h-18.30h
👉 Registration: us02web.zoom.us/webinar/regi…
Us hi esperem‼️🧬🩺🔬
@ICO_oncologia @GTRecerca @hgermanstrias
Molt agraïda per la beca SEOM i el reconeixement de @_SEOM! Gràcies especialment a @CespedesMontse, @NadalErnest, Dr. David Barbie pel #mentoring rebut🩺🔬
📍Save the date! B·ARGO Translational Research in Lung Cancer 3rd edition 🔬🫁
🗓️14 June, 14h
🏥 Sala Polivalent IGTP Mar
👉 Registration germanstrias.org/ca/agenda/7…
Us hi esperem! @ICO_oncologia @GTRecerca @hgermanstrias
📍Càncer de pulmó: prova pilot per fer-ne detecció precoç en fumadors i exfumadors ccma.cat/324/cancer-de-pulmo…
Happy to share our results from our Lung Team at #ELCC23, such a great and educational congress! 🫁🧬@ICO_oncologia Badalona @GTRecerca
Great talk about “state of the art and new insights for #SCLC #immunotherapy”by @charlesrudin at #ELCC23 🔬🩺
